YIH
ARCT icon

Y-Intercept (HK)’s Arcturus Therapeutics ARCT Stock Holding History

Y-Intercept (HK)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
+43,291
New +$341K 0.01% 1474
2025
Q3 		– Sell
-44,432
Closed -$578K – 1553
2025
Q2 		$578K Buy
44,432
+21,355
+93% +$253K 0.01% 1157
2025
Q1 		$244K Buy
+23,077
New +$366K 0.02% 976
2024
Q3 		– Sell
-17,991
Closed -$438K – 1288
2024
Q2 		$438K Buy
+17,991
New +$546K 0.02% 875

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Y-Intercept (HK)'s ARCT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 43,291 shares worth $291K. The stake represents 0.01% of the portfolio and ranks #1474 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ARCT as recently as Q2 2025.

Y-Intercept (HK) first reported a position in ARCT in Q2 2024 and has held it in 4 quarters since. The position peaked at $578K in Q2 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Y-Intercept (HK) held 43,291 shares of Arcturus Therapeutics worth $291K as of Q2 2026.
  • Arcturus Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
  • Arcturus Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1474 holding.
  • Y-Intercept (HK) first reported a position in Arcturus Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Y-Intercept (HK)'s Arcturus Therapeutics position peaked at $578K in Q2 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.